期刊文献+

原发性胆汁性肝硬化52例误诊原因分析 被引量:3

Misdiagnosis of Primary Biliary Cirrhosis:Analysis of 52 Cases
下载PDF
导出
摘要 目的 :分析原发性胆汁性肝硬化 (PBC)的误诊原因。方法 :对 1991年 1月~ 2 0 0 4年 7月诊断PBC的病例资料进行回顾性分析。结果 :期间共收治PBC 112例 ,误诊 5 2例 ,误诊率为 46 43 % ,平均误诊时间 ( 4 9 3± 62 7)个月 ,多被误诊为隐源性肝炎或隐源性肝硬化、慢性乙型肝炎、药物性肝炎、脂肪肝、干燥综合征、类风湿关节炎、皮肤瘙痒症等疾病。结论 :PBC在我国可能并非少见 ,应进一步提高对本病的认识 。 Objective:To analyze the causes for misdiagnosis of primary biliary cirrhosis (PBC).Methods:A retrospective analysis was performed on clinical data about patients diagnosed with PBC between January,1991 and July,2004.Results:During that period of time,totally 112 cases of PBC were hospitalized,but 52 of them were misdiagnosed,accounting for 46.43%.The mean time needed for correct dignosis was 49.3±6.27 months.The misdiagnosis mainly included:cryptogenetic hepatitis or cirrhosis,chronic hepatitis B,drug induced hepatitis,fatty liver,Sjogren's syndrome,rheumatoid arthritis and cutaneous pruritus.Conclusions:PBC is not uncommon in China.Therefore,much more attention should be paid to understanding of the disease so as to reduce the misdianosis.
出处 《临床误诊误治》 2005年第2期90-91,共2页 Clinical Misdiagnosis & Mistherapy
关键词 肝硬化 胆汁性 误诊 肝炎 脂肪肝 瘙痒症 Cirrhosis,biliary Misdiagnosis Hepatilis Fatty liver Pruritus
  • 相关文献

参考文献6

二级参考文献22

  • 1Bandin O, Courvalin JC, Poupon R, et al. Specificity and sensitivity of gp210 autoantibodies detected using an enzyme-linked immunosorbent assay and a synthetic polypeptide in the diagnosis of primary biliary cirrhosis. Hepatology, 1996, 23: 1020-1024. 被引量:1
  • 2Bach N, Odin JA. Primary biliary cirrhosis: a Mount Sinai perspective. Mt Sinai J Med, 2003, 70: 242-250. 被引量:1
  • 3Kamihira T, Shimoda S, Harada K, et al. Distinct costimulation dependent and independent autoreactive T-cell clones in primary biliary cirrhosis. Gastroenterology, 2003, 125: 1379-1387. 被引量:1
  • 4Mitchison HC, Palmer JM, Bassendine MF, et al. A controlled trial of prednisolone treatment in primary biliary cirrhosis: threeyear results. J Hepatol, 1992, 15: 336-344. 被引量:1
  • 5Leuschner M, Guldutuna S, You T, et al. Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis. J Hepatol,1996, 25: 49-57. 被引量:1
  • 6Chan CW, Papatheodoridis GV, Goulis J, et al. Ursodeoxycholic acid and histological progression in primary biliary cirrhosis. J Hepatol, 2003, 39: 1094-1095. 被引量:1
  • 7Talwalkar JA, Lindor KD. Primary biliary cirrhosis. Lancet, 2003,262: 53-61. 被引量:1
  • 8Muratori P, Muratori L, Ferrari R, et al. Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis. Am J Gastroenterol, 2003, 98: 431-437. 被引量:1
  • 9Ikuno N, Mackay IR, Jois J, et al. Antimitochondrial autoantibodies in saliva and sera from patients with primary biliary cirrhosis.J Gastroenterol Hepatol, 2001, t6: 1390-1394. 被引量:1
  • 10Metcalf JV, Mitchison HC, Palmer JM, et al. Natural history of early primary biliary cirrhosis. Lancet, 1996, 348: 1399-1402. 被引量:1

共引文献158

同被引文献33

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部